- Home
- AMPX vs AQST Comparison
AMPX vs AQST Comparison
Compare AMPX & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPX
- AQST
- Stock Information
- Founded
- AMPX 2008
- AQST 2004
- Country
- AMPX United States
- AQST United States
- Employees
- AMPX N/A
- AQST N/A
- Industry
- AMPX Industrial Machinery/Components
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- AMPX Miscellaneous
- AQST Health Care
- Exchange
- AMPX Nasdaq
- AQST Nasdaq
- Market Cap
- AMPX 261.0M
- AQST 285.4M
- IPO Year
- AMPX N/A
- AQST 2018
- Fundamental
- Price
- AMPX $3.35
- AQST $3.10
- Analyst Decision
- AMPX Strong Buy
- AQST Strong Buy
- Analyst Count
- AMPX 7
- AQST 8
- Target Price
- AMPX $8.43
- AQST $10.38
- AVG Volume (30 Days)
- AMPX 5.2M
- AQST 1.5M
- Earning Date
- AMPX 11-07-2024
- AQST 03-04-2025
- Dividend Yield
- AMPX N/A
- AQST N/A
- EPS Growth
- AMPX N/A
- AQST N/A
- EPS
- AMPX N/A
- AQST N/A
- Revenue
- AMPX $17,480,000.00
- AQST $58,900,000.00
- Revenue This Year
- AMPX $132.87
- AQST $18.44
- Revenue Next Year
- AMPX $234.98
- AQST N/A
- P/E Ratio
- AMPX N/A
- AQST N/A
- Revenue Growth
- AMPX 196.22
- AQST 22.56
- 52 Week Low
- AMPX $0.61
- AQST $2.24
- 52 Week High
- AMPX $4.70
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- AMPX 59.22
- AQST 34.77
- Support Level
- AMPX $3.17
- AQST $2.96
- Resistance Level
- AMPX $3.90
- AQST $3.30
- Average True Range (ATR)
- AMPX 0.64
- AQST 0.21
- MACD
- AMPX 0.02
- AQST 0.01
- Stochastic Oscillator
- AMPX 57.46
- AQST 16.87
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high energy density lithium-ion batteries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. All of its revenues is geographically earned in the United States.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.